Well Health Tech Stock Price, News & Analysis

WELL Health Technologies (OTCQX:WHTCF), a digital healthcare company, has scheduled its Second Quarter 2025 financial results announcement for August 14, 2025, before market opening.

The company will host a conference call and webcast on the same day at 1:00 PM ET to discuss the results. CEO Hamed Shahbazi and CFO Eva Fong will lead the discussion. Participants can join via phone using North American toll-free number 1-800-717-1738 or international number 289-514-5100.

WELL Health Technologies (TSX: WELL, OTC: WHTCF) has provided an updated corporate outlook for its Canadian Clinics Business, announcing significant growth and improved financial guidance. The company has raised its 2025 guidance for Canadian Patient Services to over $450 million in revenue (41% YoY increase) and over $60 million in Adjusted EBITDA (47% YoY increase).

Key developments include: (1) Two strategic clinic acquisitions in British Columbia completed on July 1, 2025, expected to add $12 million in annual revenue and $3 million in Adjusted EBITDA; (2) An expanded credit facility led by RBC, increased to $200 million and extended to 2027; (3) A robust M&A pipeline of 124 clinics representing $370 million in potential revenue; and (4) Implementation of a multi-million-dollar cost optimization initiative across Canadian operations.

WELL Health Technologies (OTCQX:WHTCF), a digital healthcare company, has announced the voting results from its annual general meeting held on June 30, 2025. All nominated directors were successfully elected, with 67,105,724 common shares (representing 26.52% of outstanding shares) voted by proxy.

The election results showed varying levels of support for the directors, with Sybil E Jen Lau receiving the highest approval at 97.61%, while CEO and Chairman Hamed Shahbazi received 73.15% support. Other directors, including John Kim (94.42%), Thomas Liston (87.80%), Tara McCarville (87.51%), and Kenneth Cawkell (82.45%), were also elected.

WELL Health Technologies (OTCQX:WHTCF) has announced a significant expansion in primary care capacity, opening 45,000+ new patient slots across Ontario (13,000+), Alberta (~21,000), and Manitoba (11,000+). This expansion is driven by successful physician recruitment, particularly internationally trained doctors, and digital transformation initiatives.

The company is leveraging WELLSTAR Technologies to power its clinics with advanced digital workflows, including the Nexus AI™ ambient scribe and OceanMD's patient engagement platform. Through its subsidiary Physicians For You, WELL has placed 25 new internationally trained physicians in the last 6 months and plans to onboard 20 more in 2025.

CRH Medical Corporation, a subsidiary of WELL Health Technologies Corp., has formed a strategic partnership with WovenX Health to enhance gastrointestinal (GI) care delivery. The collaboration combines CRH's clinical GI solutions with WovenX's virtual visit platform to improve patient access and operational efficiency. WovenX's on-demand service helps practices increase appointment availability, optimize procedural capacity, and streamline workflows. The partnership aims to address traditional barriers in GI care access while enabling practices to capture new growth opportunities and downstream revenue. Dr. Russ Arjal, WovenX's Co-Founder and CMO, highlighted their high Net Promoter Score and ability to deliver guideline-based care quickly, while CRH's CEO Jay Kreger emphasized how the partnership extends their existing solutions to GI physicians.

WELL Health Technologies (WHTCF) has appointed Ric Leong as Chief Accounting Officer, effective May 20th. Leong, who holds CPA, CA credentials and a BSc degree, will lead WELL's accounting operations and financial planning functions. He brings significant experience from his previous roles as CFO of Avigilon during its $1B acquisition by Motorola Solutions, and most recently as SVP of Finance at Hootsuite. In his new role, Leong will focus on strengthening financial reporting processes, supporting WELL's acquisition strategy through financial integration, and enhancing financial planning and analysis capabilities. He will report to CFO Eva Fong and work closely with WELL's leadership team to support the company's growth objectives in the digital healthcare sector.

WELL Health Technologies (WHTCF) announces that three of its subsidiaries - Intrahealth, Pentavere, and OceanMD - have been selected for Canada Health Infoway's 2025 Vendor Innovation Program. These subsidiaries, representing three out of eight total winners, will develop projects focused on improving healthcare interoperability across Canada. Pentavere will integrate its DARWEN™ AI system with EMRs, OceanMD will enhance its eReferral system with AI automation, and Intrahealth will develop FHIR-based tools for patient record transfers. The projects will be implemented across multiple provinces including Alberta, British Columbia, Ontario, New Brunswick, and Nova Scotia, aiming to improve data quality, enhance care coordination, and expand access to standardized health information.

WELL Health Technologies (WHTCF) has established an automatic share purchase plan (ASPP) to facilitate its previously announced normal course issuer bid (NCIB). The company received TSX approval to repurchase up to 6,326,417 common shares, representing approximately 2.5% of its 253,056,708 outstanding shares, between May 20, 2025, and May 19, 2026.

The ASPP allows WELL's broker to purchase shares during periods when the company would typically be restricted from trading due to insider trading rules and internal blackout periods. Purchases will be made based on pre-set parameters established by WELL when it has no undisclosed material information.

["Company authorized to repurchase 6.3M shares (2.5% of outstanding shares)", "ASPP enables consistent share repurchases even during blackout periods", "Share buyback demonstrates management's confidence in company value"]

WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) has received approval from the Toronto Stock Exchange for its renewed Normal Course Issuer Bid (NCIB). The program allows WELL to repurchase up to 6,326,417 shares, representing 2.5% of its outstanding shares, over a 12-month period from May 20, 2025 to May 19, 2026.

Daily purchases on the TSX will be limited to 284,830 shares. Under the previous 2024 NCIB, WELL purchased 298,500 shares at an average price of $4.91. The company's limited buyback activity was due to their previous broker Eight Capital winding down operations and funds being allocated to alternative opportunities.